Loading, please wait ...


News Analytics

leopharma.
The primary endpoint for the randomized, double-blind, vehicle-controlled, multi-center Phase 2b dose-finding trial was the proportion of adult patients with mild-to-severe CHE who achieved an Investigator’s Global Assessment (IGA)-CHE score of 0 (clear) or 1 (almost clear) with a ≥2 point improvement from baseline, at week 16.1 A key secondary endpoint was change in Hand Eczema Severity Index (HECSI) from baseline to ...
Google

Subject Matter

  • Healthcare 68.75%
    • Hospitals, doctors and medical care 100.00%
  • Science and technology 31.25%

Emotional Reaction

Sentiment

Positive

Neutral

Negative

Definitions